a Leibniz-Institut für Analytische Wissenschaften-ISAS-e.V., Dortmund , Germany.
b Department of Biochemistry , CARIM, Maastricht University , Maastricht , The Netherlands.
Expert Rev Proteomics. 2018 Jun;15(6):467-476. doi: 10.1080/14789450.2018.1480111. Epub 2018 Jun 8.
Platelets are the smallest cells within the circulating blood with key roles in physiological hemostasis and pathological thrombosis regulated by the onset of activating/inhibiting processes via receptor responses and signaling cascades. Areas covered: Proteomics as well as genomic approaches have been fundamental in identifying and quantifying potential targets for future diagnostic strategies in the prevention of bleeding and thrombosis, and uncovering the complexity of platelet functions in health and disease. In this article, we provide a critical overview on current functional tests used in diagnostics and the future perspectives for platelet proteomics in clinical applications. Expert commentary: Proteomics represents a valuable tool for the identification of patients with diverse platelet associated defects. In-depth validation of identified biomarkers, e.g. receptors, signaling proteins, post-translational modifications, in large cohorts is decisive for translation into routine clinical diagnostics.
血小板是循环血液中最小的细胞,通过受体反应和信号级联等激活/抑制过程的发生,在生理止血和病理血栓形成中起着关键作用。
蛋白质组学和基因组学方法对于确定和量化未来预防出血和血栓形成的诊断策略的潜在靶点至关重要,同时也揭示了血小板在健康和疾病中的功能的复杂性。在本文中,我们提供了对当前诊断中使用的功能测试以及血小板蛋白质组学在临床应用中的未来前景的批判性综述。
蛋白质组学是识别具有不同血小板相关缺陷的患者的有价值的工具。对所鉴定的生物标志物(例如受体、信号蛋白、翻译后修饰)进行深入验证,对于将其转化为常规临床诊断至关重要。